Skip to main content
. 2023 Feb 28;24(2):141–157. doi: 10.1089/sur.2022.393

Table 12.

Other Outcomes

 
Pre-intervention cohort (n = 139)
Post-intervention cohort (n = 126)
 
Endpoint n % n % p
Patient with non-infectious complications at 30 d 64 46.0 51 40.5 0.361
Re-hospitalization within 30 d 23 16.6 14 11.1 0.202
Discharged to a long-term or another facility 37 26.7 21 16.7 0.050
  Median IQR Median IQR p
Hospital days
8
5–16
8
5–13
0.428
ICU days
1
0–4
1
0–4
0.571
Ventilator days
0
0–2
0
0–2
0.966
Days receiving anti-Infective agents
5
2–14
3
1–11
0.009
Days receiving prophylactic anti-infective agents
2
1–4
2
1–3
0.107
Days receiving empiric anti-infective agents
0
0–0
0
0–0
0.128
Days receiving anti-infective agents for treatment of an infection
0
0–10
0
0–8
0.035
Days receiving anti-infective agents for treatment of a related infection
0
0–0
0
0–0
0.275
Days in which all anti-infective agents administered were considered inappropriate
0
0–1
0
0–1
0.227
Days in which any anti-infective agent administered was considered inappropriate 1 0–5 0 0–3 0.046

IQR = interquartile range; ICU = intensive care unit